<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3C9DBFA2-5A72-43E0-9FCE-BEB5B3BD416E"><gtr:id>3C9DBFA2-5A72-43E0-9FCE-BEB5B3BD416E</gtr:id><gtr:name>Iqur Limited</gtr:name><gtr:address><gtr:line1>THE LONDON BIOSCIENCE INNOVATION CENTRE , 2 ROYAL COLLEGE STREET</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1 0NH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3C9DBFA2-5A72-43E0-9FCE-BEB5B3BD416E" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>3C9DBFA2-5A72-43E0-9FCE-BEB5B3BD416E</gtr:id><gtr:name>Iqur Limited</gtr:name><gtr:address><gtr:line1>THE LONDON BIOSCIENCE INNOVATION CENTRE , 2 ROYAL COLLEGE STREET</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1 0NH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>51737.0</gtr:offerGrant><gtr:projectCost>95649.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>100000.0</gtr:offerGrant><gtr:projectCost>100000.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/62ADD11D-8A50-4842-A4C4-059EDD8B2264"><gtr:id>62ADD11D-8A50-4842-A4C4-059EDD8B2264</gtr:id><gtr:firstName>Mike</gtr:firstName><gtr:surname>Whelan</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=131266"><gtr:id>47F776E4-C702-4A8E-A6EC-8B3A00610995</gtr:id><gtr:title>Development of a novel VLP based vaccine for malaria</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>131266</gtr:grantReference><gtr:abstractText>Malaria remains a major cause of death, particularly in many developing countries. Currently no vaccine is commercially available and existing pharmaceuticals are becoming less and less effective due to parasitic resistance, while insecticide resistance in diminishing the utility of that intervention. Therefore, we propose to develop an new and potent vaccine using a delivery system developed by iQur Ltd and malaria antigens under development by the Jenner Institute at Oxford University. In this feasibility study, we will prepare a virus like particle (VLP), which will carry the malaria target antigens, and test these vaccines for safety, immunogenicity and efficacy in mice. VLPs are well accepted as a safe delivery system and give rise to strong immune responses. If this study is successful, we will then initiate a clinical development programme which will bring this vaccine to market</gtr:abstractText><gtr:fund><gtr:end>2014-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2013-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>151737</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">131266</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>